Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response

• Shu Lin,
• Lifeng Yu,
• Xinyue Song,
• Jia Bi,
• Longyang Jiang,
• Yan Wang,
• Miao He,
• Qinghuan Xiao,
• Mingli Sun,
• Olufunmilayo I. Olopade,
• Lin Zhao,
• Minjie Wei

Affiliations

Shu Lin

Department of Pharmacology, School of Pharmacy, China Medical University

Lifeng Yu

Department of Pharmacology, School of Pharmacy, China Medical University

Xinyue Song

Department of Pharmacology, School of Pharmacy, China Medical University

Jia Bi

Department of Pharmacology, School of Pharmacy, China Medical University

Longyang Jiang

Department of Pharmacology, School of Pharmacy, China Medical University

Yan Wang

Department of Pharmacology, School of Pharmacy, China Medical University

Miao He

Department of Pharmacology, School of Pharmacy, China Medical University

Qinghuan Xiao

Department of Pharmacology, School of Pharmacy, China Medical University

Mingli Sun

Department of Pharmacology, School of Pharmacy, China Medical University

Olufunmilayo I. Olopade

Section of Hematology/Oncology, Department of Medicine, University of Chicago

Lin Zhao

Department of Pharmacology, School of Pharmacy, China Medical University

Minjie Wei

Department of Pharmacology, School of Pharmacy, China Medical University